Warrants - Schedule of Warrants Outstanding (Details) |
9 Months Ended |
|---|---|
|
Sep. 30, 2020
$ / shares
shares
| |
| Equity [Abstract] | |
| Number of Shares, Warrants Outstanding Beginning | shares | 10,930,991 |
| Number of Shares, Warrants Granted | shares | 4,630,654 |
| Number of Shares, Warrants Forfeited | shares | (244,800) |
| Number of Shares, Warrants Exercised | shares | (1,965,594) |
| Number of Shares, Warrants Outstanding Ending | shares | 13,351,251 |
| Weighted-Average Exercise Price, Outstanding Beginning | $ 3.07 |
| Weighted-Average Exercise Price, Granted | 1.17 |
| Weighted-Average Exercise Price, Forfeited | 3.53 |
| Weighted-Average Exercise Price, Exercised | 1.10 |
| Weighted-Average Exercise Price, Outstanding Ending | $ 2.50 |
| Weighted Average Remaining Contractual Life (Years), Outstanding, Beginning | 4 years 2 months 30 days |
| Weighted Average Remaining Contractual Life (Years), Outstanding Ending | 3 years 7 months 17 days |
| Aggregate Intrinsic Value Outstanding Beginning | |
| Aggregate Intrinsic Value Outstanding Ending |
| X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which forfeited can acquire shares of common stock by exercise of non-option equity. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Intrinsic value exercise price. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|